Company: IMRX
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001790340-25-000104
Chunk: 331

Company: Immuneering Corp
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 331
---
1Level 2Level 3TotalAssets:Cash equivalentsMoney market$26,105,734 $— $— $26,105,734 Total cash equivalents$26,105,734 $— $— $26,105,734 There have been no changes to the valuation methods during the six months ended June 30, 2025. There were no transfers between Level 1 and Level 2 and we had no financial assets or liabilities that were classified as Level 3 at any point during the six months ended June 30, 2025. Cash equivalents and marketable securities have been initially valued at the transaction price and subsequently, at the end of each reporting period, valued utilizing third-party pricing services or other observable market data. The pricing services 

15

utilize industry standard valuation models, including both income and market-based approaches, and observable market inputs to determine value. After completing our valuation procedures, we did not adjust or override any fair value measurements provided by the pricing services as of June 30, 2025 and December 31, 2024.The following table summarizes our cash equivalents measured at fair value on a recurring basis as of December 31, 2024:Level 1Level 2Level 3TotalAssets:Cash equivalentsMoney market$35,865,754 $— $— $35,865,754 Total cash equivalents$35,865,754 $— $— $35,865,754 

Note 5 – Property and Equipment, net

Property and equipment, net consisted of the following:June 30,2025December 31,2024Computer equipment$581,839 $570,778 Furniture and fixtures98,628 98,628 Lab equipment1,236,233 1,236,233 Leasehold improvements298,941 298,941 Total2,215,641 2,204,580 Accumulated depreciation and amortization(1,251,503)(1,081,715)Property and equipment, net$964,138 $1,122,865 Depreciation and amortization expense totaled $84,527 and $90,533 for the three months ended June 30, 2025 and 2024, respectively. Depreciation and amortization expense totaled $169,788 and $180,742 for the six months ended June 30, 2025 and 2024